Clinical Trials
First results from ongoing Phase III trial show malaria...
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria...
Clinical Trials
Acetylon Pharma starts treating patients in Phase 1-2a multiple...
Acetylon Pharmaceuticals has started treating patients in a three-part Phase 1-2a trial to evaluate ACY-1215 in adult patients suffering from relapsed and relapsed/refractory multiple...
Clinical Trials
Neurocrine starts tardive dyskinesia drug Phase II trial
US based Neurocrine Biosciences has started a second double-blind, placebo controlled, randomized cross-over Phase II trial to evaluate NBI- 98854. ...
Clinical Trials
Bionor Pharma to initiate HIV Vacc-4x combination trial
Bionor Pharma is set to initiate a double blinded, randomized and placebo-controlled trial to evaluate HIV-vaccine candidate Vacc-4x in combination with Revlimid.Revlimid is indicated as...
Clinical Trials
Scancell updates on cancer vaccine Phase I clinical trial
The Cohort Review Committee has approved Scancell to further escalate cancer vaccine SCIB1 dose to 4mg from the current 2mg in the Phase I clinical...
Clinical Trials
Aeras, OETC commence TB drug Phase IIb trial
Aeras and the Oxford-Emergent Tuberculosis Consortium (OETC) have commenced a Phase IIb trial to investigate a new experimental tuberculosis vaccine in TB patients with human...
Clinical Trials
Alnylam concludes liver cancer drug Phase I trial
US based drug developer Alnylam Pharmaceuticals has concluded an open label, multi-center, dose escalation Phase I trial evaluating ALN-VSP as a treatment for advanced solid...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.